Compare · BLDP vs TMO
BLDP vs TMO
Side-by-side comparison of Ballard Power Systems Inc. (BLDP) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BLDP operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $183.60B, about 96.7x BLDP ($1.90B).
- TMO has been more active in the news (17 items in the past 4 weeks vs 3 for BLDP).
- Both have 25 recent analyst ratings on file.
- Company
- Ballard Power Systems Inc.
- Thermo Fisher Scientific Inc
- Price
- $6.29+0.16%
- $493.55+0.20%
- Market cap
- $1.90B
- $183.60B
- 1M return
- -
- +2.96%
- 1Y return
- -
- +24.50%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 17
- Recent ratings
- 25
- 25
Ballard Power Systems Inc.
Ballard Power Systems Inc. engages in the design, development, manufacture, sale, and service of proton exchange membrane fuel cell products primarily in Canada. The company offers heavy duty modules, marine systems, fuel cell stacks, backup power systems, and material handling products. It also provides technology solutions, including engineering and technology transfer, as well as the licenses and sells intellectual property portfolio and fundamental knowledge for various proton exchange membrane fuel cell applications. The company serves transit bus, rail, critical infrastructure, marine, material handling, stationary power, truck, and automotive markets. It markets its products in China, Germany, the United States, the United Kingdom, Belgium, Japan, Denmark, France, Taiwan, Norway, Spain, the Netherlands, Finland, Switzerland, and internationally. Ballard Power Systems Inc. has a strategic alliance with Linamar Corporation for the co-development and sale of fuel cell powertrains and components for class 1 and 2 vehicles in North America and Europe. The company was founded in 1979 and is headquartered in Burnaby, Canada.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BLDP
- SEC Form SD filed by Ballard Power Systems Inc.
- SEC Form 6-K filed by Ballard Power Systems Inc.
- Ballard Announces Resignation of Weichai's Nominee Directors and Sale of Weichai's Shares
- SEC Form 6-K filed by Ballard Power Systems Inc.
- TD Cowen reiterated coverage on Ballard Power with a new price target
- SEC Form 6-K filed by Ballard Power Systems Inc.
- Ballard Power upgraded by Lake Street with a new price target
- SEC Form 6-K filed by Ballard Power Systems Inc.
- SEC Form 6-K filed by Ballard Power Systems Inc.
- Ballard Reports Q1 2026 Results
Latest TMO
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
- Director Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)
- Director Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)